Title |
EX-PRESS Glaucoma Filtration Device: efficacy, safety, and predictability
|
---|---|
Published in |
Medical Devices : Evidence and Research, September 2015
|
DOI | 10.2147/mder.s63350 |
Pubmed ID | |
Authors |
Jessica E Chan, Peter A Netland |
Abstract |
Trabeculectomy has been the traditional primary surgical therapy for open-angle glaucoma. While trabeculectomy is effective in lowering intraocular pressure, complications associated with the procedure have motivated the development of alternative techniques and devices, including the EX-PRESS Glaucoma Filtration Device. This review describes the efficacy, safety, complication rates, and potential advantages and disadvantages of the EX-PRESS Glaucoma Filtration Device. EX-PRESS implantation is technically simpler compared with that of trabeculectomy, with fewer surgical steps. Vision recovery has been more rapid after EX-PRESS implantation compared with trabeculectomy. Intraocular pressure variation is lower during the early postoperative period, indicating a more predictable procedure. While efficacy of the EX-PRESS implant has been comparable to trabeculectomy, postoperative complications appear less common after EX-PRESS implantation compared with trabeculectomy. The EX-PRESS Glaucoma Filtration Device appears to be safe and effective in the surgical management of open-angle glaucoma. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Venezuela, Bolivarian Republic of | 1 | 3% |
Unknown | 33 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 6 | 18% |
Student > Master | 5 | 15% |
Student > Doctoral Student | 4 | 12% |
Student > Bachelor | 4 | 12% |
Other | 3 | 9% |
Other | 5 | 15% |
Unknown | 7 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 14 | 41% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 12% |
Engineering | 4 | 12% |
Agricultural and Biological Sciences | 2 | 6% |
Neuroscience | 2 | 6% |
Other | 2 | 6% |
Unknown | 6 | 18% |